Sreetama Dutt is a news curator and columnist at Hepatitis News Today. She studied biotechnology at SRM Institute of Science and Technology, and did her Masters in medical microbiology at University of Manchester in Manchester, UK.
In a recent press release from Bristol-Myers Squibb, officials announced the success of their ongoing phase III clinical trial, ALLY-1, in meeting its predicted end-points. The trial had been conducted ... Read more
Australia is on the verge of becoming a pioneer in formulating a possible cure for chronic Hepatitis B infections and related complications, like cirrhosis and liver cancer. According to a ... Read more
Pin It on Pinterest